AXA shareholder 'very disappointed' by Astra board

One of the major shareholders in AstraZeneca has criticised the board following its rejection of Pfizer's "final" £69 billion takeover bid.

ITV News Business Editor Joel Hills reports:


Richard Marwood, of Axa tells me "very disappointed" by AZ board "not in shareholders interests" and "very hard to do a deal from here"

Read: Is Pfizer's failed final bid the end of takeover saga?


Pfizer admits defeat on AstraZeneca bid

US pharmaceuticals giant Pfizer has called off its multi-billion pound bid to take over British-Swedish firm AstraZeneca. The decision came after AstraZeneca's board declined an offer worth almost £70bn.